A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia

Clinical trial NCT03271541 · COMPLETED

Trial details

NCT number: NCT03271541
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Beta-Thalassemia

Start date: 2017-10-26
Primary completion: 2018-06-29
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.